Cantor Fitzgerald Maintains Overweight on Tenet Healthcare, Raises Price Target to $168
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James maintains an Overweight rating on Tenet Healthcare (NYSE:THC) and raises the price target from $112 to $168.
July 25, 2024 | 1:50 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald analyst Sarah James maintains an Overweight rating on Tenet Healthcare and raises the price target from $112 to $168.
The raised price target from $112 to $168 by a reputable analyst at Cantor Fitzgerald is a strong positive signal for Tenet Healthcare. This suggests increased confidence in the company's future performance, likely leading to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100